Idebenone is an antioxidative agent with therapeutic efficacy for Friedreich’s ataxia (FRDA) based on the upregulation of NRF2 mRNA and protein levels, as assessed in fibroblasts derived from the skin of FRDA patients (40). The gene discussed is NFE2L2; the disease is Friedreich ataxia.